Today we bring you a staggering story about a UK-based surgeon who was diagnosed with Hepatitis C in 2008. One of the biggest Hepatitis C stories of 2016 Jump to 2016: Yesterday more than 8000 of his former patients were mailed an invitation to take a Hepatitis C drug test and the story quickly hit […]
Author Archives: Marko
"What would have taken a hundred years for us to achieve, is now at hand!" were the first words of Prof. Angelos Hatzakis who serves at EU Council in Brussels as a co-chair of Hepatitis B and C Public Policy Association. In light of recent discoveries, Europe has presented the so-called Hepatitis C Elimination Manifesto the purpose […]
In the world of Hepatitis C patients, Twinvir started to pick on mythical proportions. It seldom happens that a generic drug, no matter how successful, becomes so quickly known to the patients who need it. Twinvir pills (sofosbuvir 400 mg / ledipasvir 90 mg) produced by Incepta Pharmaceuticals in currently one of the best-selling generic medications in […]
Gilead Sciences, a pharmaceutical giant, has launched very effective yet pricey drug for the Hepatitis C patients. The company justifies the $94,500 price of Harvoni and $84,000 for Sovaldi for a 12 week course on the basis of its success rate at curing the disease and preventing future costs of hospitalization, liver cancer and transplants. […]
Hepatitis C is an infection that leads to the inflammation of the liver. Hepatitis C can be transmitted from person to person in various ways; the most predominant via the use of drug injections (60%) as you can see on the pie chart on the right. What does the liver do? The liver is responsible […]
Today I have some good news for Hepatitis C patients with genotype 1 or genotype 4. In the beginning of February 2016, pharmaceutical giant Merck has entered Hepatitis C treatment market by introducing a completely new drug. Under its trademark, it is known as Zepatier. What is more, Zepatier consists of a completely new set […]
In a surprising and warm-hearted gesture, the Australian government announced in December 2015 that they will pay for all Hepatitis C medications Australians need. They pledged a whole of $1 billion to the cause. The announcement came from Health Minister Sussan Ley, representing Turnbull's government. Hepatitis C in Australia by numbers According to Australian Hepatitis […]
Hepatitis C has long been a formidable disease with a high death toll and inadequate treatment. However, in the recent years we have seen much more successful treatment options on a backbone of a newly discovered therapeutic molecule called sofosbuvir. Sofosbuvir is an antiviral molecule, structurally similar to existing antivirals, but it has proven to be […]
Hepatitis C has long been a formidable disease with a high death toll and inadequate treatment. However, in the recent years we have seen much more successful treatment options on a backbone of a newly discovered therapeutic molecule called sofosbuvir. Sofosbuvir is an antiviral molecule, structurally similar to existing antivirals, but it has proven to be […]